228 related articles for article (PubMed ID: 17957129)
1. Effect of arsenic trioxide on uveal melanoma cell proliferation in vitro.
Wang C; Li B; Zhang H; Shi G; Li W; Jonas JB
Ophthalmic Res; 2007; 39(6):302-7. PubMed ID: 17957129
[TBL] [Abstract][Full Text] [Related]
2. A novel combination therapy with arsenic trioxide and parthenolide against pancreatic cancer cells.
Wang W; Adachi M; Zhang R; Zhou J; Zhu D
Pancreas; 2009 May; 38(4):e114-23. PubMed ID: 19342982
[TBL] [Abstract][Full Text] [Related]
3. [In vitro study on inhibition of human choroidal melanoma OCM-1 cell line by arsenic trioxide].
Wang CF; Li B; Zhang HY; Li WH; Sun YL; Xu YL
Zhonghua Yan Ke Za Zhi; 2005 Oct; 41(10):887-91. PubMed ID: 16271172
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of arsenic trioxide on retinoblastoma: cell differentiation and apoptosis depending on arsenic trioxide concentration.
Kim JH; Kim JH; Yu YS; Kim DH; Kim CJ; Kim KW
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1819-23. PubMed ID: 19060284
[TBL] [Abstract][Full Text] [Related]
5. Arsenic trioxide mediates intrinsic and extrinsic pathways of apoptosis and cell cycle arrest in acute megakaryocytic leukemia.
Lam HK; Li K; Chik KW; Yang M; Liu VC; Li CK; Fok TF; Ng PC; Shing MM; Chuen CK; Yuen PM
Int J Oncol; 2005 Aug; 27(2):537-45. PubMed ID: 16010437
[TBL] [Abstract][Full Text] [Related]
6. Effects of arsenic trioxide on cell death, reactive oxygen species and glutathione levels in different cell types.
Han YH; Moon HJ; You BR; Kim SZ; Kim SH; Park WH
Int J Mol Med; 2010 Jan; 25(1):121-8. PubMed ID: 19956910
[TBL] [Abstract][Full Text] [Related]
7. Arsenic trioxide inhibits the growth of Calu-6 cells via inducing a G2 arrest of the cell cycle and apoptosis accompanied with the depletion of GSH.
Han YH; Kim SZ; Kim SH; Park WH
Cancer Lett; 2008 Oct; 270(1):40-55. PubMed ID: 18539383
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase C is involved in arsenic trioxide-induced apoptosis and inhibition of proliferation in human bladder cancer cells.
Wang Y; An R; Dong X; Pan S; Duan G; Sun X
Urol Int; 2009; 82(2):214-21. PubMed ID: 19322013
[TBL] [Abstract][Full Text] [Related]
9. Effect of arsenic trioxide (ATO) on human lung carcinoma PG cell line: ATO induced apoptosis of PG cells and decreased expression of Bcl-2, Pgp.
Han B; Zhou G; Zhang Q; Zhang J; Wang X; Tang W; Kakudo K
J Exp Ther Oncol; 2004 Dec; 4(4):335-42. PubMed ID: 15844663
[TBL] [Abstract][Full Text] [Related]
10. Arsenic trioxide inhibits metastatic potential of mouse hepatoma H22 cells in vitro and in vivo.
Zhao XS; Song PL; Sun B; Jiang HC; Liu TF
Hepatobiliary Pancreat Dis Int; 2009 Oct; 8(5):510-7. PubMed ID: 19822495
[TBL] [Abstract][Full Text] [Related]
11. Effects of arsenic trioxide under different administration ways on T-cell lymphoma xenografts in nude mice: in vivo and in vitro experiments.
Gao Y; Cai QQ; Li S; Bu Q; Liao H; Zhou Y; Huang HQ
Ai Zheng; 2009 Feb; 28(2):127-31. PubMed ID: 19550119
[TBL] [Abstract][Full Text] [Related]
12. Elimination of the differential chemoresistance between the murine B-cell lymphoma LY-ar and LY-as cell lines after arsenic (As2O3) exposure via the overexpression of gsto1 (p28).
Giri U; Terry NH; Kala SV; Lieberman MW; Story MD
Cancer Chemother Pharmacol; 2005 Jun; 55(6):511-21. PubMed ID: 15761769
[TBL] [Abstract][Full Text] [Related]
13. Sustained activation of c-jun-N-terminal kinase plays a critical role in arsenic trioxide-induced cell apoptosis in multiple myeloma cell lines.
Kajiguchi T; Yamamoto K; Iida S; Ueda R; Emi N; Naoe T
Cancer Sci; 2006 Jun; 97(6):540-5. PubMed ID: 16734734
[TBL] [Abstract][Full Text] [Related]
14. Arsenic trioxide induces apoptosis in cells of MOLT-4 and its daunorubicin-resistant cell line via depletion of intracellular glutathione, disruption of mitochondrial membrane potential and activation of caspase-3.
Hu XM; Hirano T; Oka K
Cancer Chemother Pharmacol; 2003 Jul; 52(1):47-58. PubMed ID: 12750841
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis in arsenic trioxide-treated Calu-6 lung cells is correlated with the depletion of GSH levels rather than the changes of ROS levels.
Han YH; Kim SH; Kim SZ; Park WH
J Cell Biochem; 2008 Jun; 104(3):862-78. PubMed ID: 18393359
[TBL] [Abstract][Full Text] [Related]
16. Arsenic Trioxide inhibits the growth of human ovarian carcinoma cell line.
Bornstein J; Sagi S; Haj A; Harroch J; Fares F
Gynecol Oncol; 2005 Dec; 99(3):726-9. PubMed ID: 16243384
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of arsenic trioxide-induced apoptosis in HeLa cells by diethyldithiocarbamate or buthionine sulfoximine.
Han YH; Kim SZ; Kim SH; Park WH
Int J Oncol; 2008 Jul; 33(1):205-13. PubMed ID: 18575767
[TBL] [Abstract][Full Text] [Related]
18. Arsenic trioxide-induced apoptosis and its enhancement by buthionine sulfoximine in hepatocellular carcinoma cell lines.
Kito M; Akao Y; Ohishi N; Yagi K; Nozawa Y
Biochem Biophys Res Commun; 2002 Mar; 291(4):861-7. PubMed ID: 11866444
[TBL] [Abstract][Full Text] [Related]
19. The effect of MAPK inhibitors on arsenic trioxide-treated Calu-6 lung cells in relation to cell death, ROS and GSH levels.
Han YH; Moon HJ; You BR; Kim SZ; Kim SH; Park WH
Anticancer Res; 2009 Oct; 29(10):3837-44. PubMed ID: 19846917
[TBL] [Abstract][Full Text] [Related]
20. Arsenic trioxide induces multiple myeloma cell apoptosis via disruption of mitochondrial transmembrane potentials and activation of caspase-3.
Jia P; Chen G; Huang X; Cai X; Yang J; Wang L; Zhou Y; Shen Y; Zhou L; Yu Y; Chen S; Zhang X; Wang Z
Chin Med J (Engl); 2001 Jan; 114(1):19-24. PubMed ID: 11779429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
